Phase II Multi-Site Randomized Controlled Trial Testing Integrated Kidney Palliative Care Compared With Usual Chronic Kidney Disease Care (Kidney RISE)
NYU Langone Health
Summary
The purpose of study is to investigate whether adding palliative care to usual chronic kidney disease (CKD) care improves symptoms and quality of life for people with CKD. The primary objectives are to 1) determine efficacy of Kidney Palliative Care (KPC) integrated with CKD care on symptom burden compared with usual CKD care, 2) identify clinical and demographic factors associated with differential responses to KPC, and 3) characterize participant and provider experiences with kidney care and factors influencing implementation.
Eligibility
- Age range
- 18+ years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: 1. Receive care at nephrology clinics or dialysis centers associated with each site. 2. Have CKD stage IV, V (eGFR \< 30 mL/min/1.73m2), or be receiving chronic dialysis 3. Speak Spanish or English, and report at IPOS-Renal score of ≥ 3 on a screening survey. 4. Willing to be randomized to either study arm and to comply with the study procedures for the assigned group. Exclusion Criteria: 1. Unable to provide informed consent 2. Has received palliative care (inpatient or outpatient) in the last six months. 3. Enrolled in hospice 4. Has any urgent palliative care needs (i…
Interventions
- BehavioralKidney RISE
Core components include assessment of symptoms (IPOS-Renal), illness understanding, goals of care, advance care planning, spiritual needs, and screening for health-related social needs (HRSNs) using the validated Centers for Medicare and Medicaid Services (CMS) Accountable Health Communities (AHC) Survey. Plans will address symptom management with evidence-based algorithms, linkage to social or spiritual supports, and shared decision-making appropriate to CKD stage.
Locations (2)
- Emory UniversityAtlanta, Georgia
- NYU Langone HealthNew York, New York